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Background: Previous studies suggested that RhoA/ROCK pathway was involved in diabetic vascular complications. The present study was 
designed to investigate whether inhibition of Rho/ROCK pathway by fasudil would prevent vessel impairment induced by high glucose (HG) and its 
underlying mechanisms.
Method: Monocyte-endothelial cell adhesion was determined using fluorescence-labeled monocytes. The mRNA and protein expressions of vascular 
cell adhesion molecule-1 (VCAM-1) and chemotactic factors monocyte chemoattractant protein-1 (MCP-1) were measured using real-time PCR 
and western blot. The protein levels of RhoA, ROCK1 and p-MYPT were determined using western blot analysis. ELISA was employed to measure the 
expression of sVCAM-1 and MCP-1 in both cell supernatant and human serum samples.
Results: Fasudil significantly suppressed HG-induced adhesion of THP-1 to HUVECs. And we further found fasudil significantly suppressed the HG-
induced mRNA and protein expression of VCAM-1 and MCP-1 through inhibiting Rho/ROCK pathway as p-MYPT/MYPT ratio was lowered in fasudil 
group than in HG group. Also, fasudil decreased MCP-1 concentration in the cell culture supernatant, but increased sVCAM-1 shedding in vitro. In 
vivo, we also confirmed that serum MCP-1 level of fasudil group was significantly decreased from 27.9 ± 10.63 pg/ml to 13.8 ± 7.01 pg/ml and 
become lower than control in diabetic patients after 2 weeks (P < 0.01), while sVCAM-1 increased from 23.2 ± 7.5 ng/ml to 32.7 ± 5.6 ng/ml after 
treatment with fasudil (P < 0.01).
Conclusions: Fasudil would prevent HG-induced vessel impairment by reducing monocyte adhesion to endothelial cells through the inhibition of 
Rho/ROCK pathway. 
